SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000912057-02-010233
Filing Date
2002-03-18
Accepted
2002-03-18 00:00:00
Documents
11
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2072042z20-f.htm 20-F 1983706
3 PDF OF 20-F a2072042zf1_20-f.pdf 20-F 705475
4 EX-1.1 a2072042zex-1_1.htm EX-1.1 76747
5 EX-2.4 a2072042zex-2_4.htm EX-2.4 242152
6 EX-10.1 a2072042zex-10_1.htm EX-10.1 1637
7 G489107.JPG g489107.jpg GRAPHIC 131731
8 G467563.JPG g467563.jpg GRAPHIC 53969
9 G463299.JPG g463299.jpg GRAPHIC 59149
10 G494491.JPG g494491.jpg GRAPHIC 119207
11 G505907.JPG g505907.jpg GRAPHIC 40635
12 G429559.JPG g429559.jpg GRAPHIC 8019
  Complete submission text file 0000912057-02-010233.txt   3424862
Mailing Address LICHSTRASSE 35 BASEL SWITZERLAND
Business Address LICHSTRASSE 35 CH 4056 BASEL SWITZE V8 00000
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-15024 | Film No.: 02577108
SIC: 2834 Pharmaceutical Preparations